Kusajili – Clinical trials directory

Result of your search per specialist: PhD Jamila Mekhloufi

Woman and Man
Between 18 years and 85 years
Merck Sharp & Dohme (MSD) Update Il y a 5 ans

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756) A Randomized, Double-Blind, Phase III Study of Pembrolizumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy for the Treatment of High-Risk Early-Stage Estro...

Country France
organs Sein
Specialty Chimiothérapie, Hormonothérapie, Immunothérapie - Vaccinothérapie

Essai ouvert aux inclusions

More information